NEWS
Wallace Bourgeois MD Awarded 2022 Damon Runyon Physician-Scientist Training Award
Dr. Bourgeois's research aims to better understand which genes can be targeted to further enhance the efficacy of Ikaros protein degraders in KMT2A-mutant AML, and ultimately help guide targeted drug development.